Coeptis Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,501 | $0 | $1,501 |
Gross Profit | -431 | -250 | -250 | 1,251 |
EBITDA | -1,499 | -2,719 | -2,672 | -3,115 |
EBIT | -1,777 | -2,969 | -2,922 | -3,365 |
Net Income | -1,828 | -3,035 | -3,001 | -3,755 |
Net Change In Cash | 0 | 1,501 | 0 | 1,501 |
Free Cash Flow | -1,892 | -1,417 | -1,902 | -1,693 |
Cash | 1,137 | 1,555 | 1,029 | 1,469 |
Basic Shares | 39,806 | 37,569 | 35,544 | 35,331 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $75 | $30 |
Gross Profit | -1,001 | -1,001 | -372 | -933 |
EBITDA | -36,354 | -32,960 | -12,814 | -8,684 |
EBIT | -37,355 | -33,962 | -13,262 | -9,008 |
Net Income | -40,967 | -40,967 | -14,422 | -7,009 |
Net Change In Cash | 0 | 0 | 75 | 30 |
Free Cash Flow | -3,875 | -3,875 | -6,239 | -3,136 |
Cash | 3,791 | 3,791 | 2,179 | 202 |
Basic Shares | 14,295 | 14,295 | 10,914 | 9,375 |
